⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JAZZ News
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases
prnewswire.com
JAZZ
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX
Form 8-K
sec.gov
JAZZ
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
prnewswire.com
JAZZ
Global Pediatric Drugs (2026-2031) - Rising Prevalence of Childhood Diseases Drives Market Growth
globenewswire.com
PFE
JNJ
GSK
SNY
NVS
PTC
BMRN
JAZZ
GILD
LLY
AMGN
AZN
MRK
ABBV
TAK
Acute Lymphoblastic Leukemia (ALL) Therapeutics Market Report 2026-2031 - Growth Sustained by Continued Clinical Innovation, Improving Pediatric Survival Outcomes and Broader MRD Adoption
globenewswire.com
AMGN
JAZZ
NVS
PFE
JNJ
GILD
MRK
ABBV
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
prnewswire.com
ALNY
ARQT
IONS
JAZZ
JNJ
MRK
PFE
AKBA
ARDX
BMY
BIIB
GILD
INSM
NVS
AGIO
BBIO
CRNX
GERN
KAVL
Form 8-K
sec.gov
JAZZ
Form 8-K
sec.gov
JAZZ
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio
prnewswire.com
JAZZ